These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39428922)

  • 1. CH25H Promotes Autophagy and Regulates the Malignant Progression of Laryngeal Squamous Cell Carcinoma Through the PI3K-AKT Pathway.
    Xiang Z; Yu S; Xu Y; Xiong H; Hu D; Li Q; Wu Z
    Cancer Med; 2024 Oct; 13(20):e70312. PubMed ID: 39428922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomal circMACF1 drives PI3K/AKT/mTOR-mediated autophagy suppression in laryngeal squamous cell carcinoma.
    Zhu Y; Duan C; Gui Y; Chen D; Su X
    Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):179-185. PubMed ID: 38372097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non‑coding RNA fer‑1‑like family member 4 serves as a tumor suppressor in laryngeal squamous cell carcinoma cells via regulating the AKT/ERK signaling pathway.
    Jiao L; Liu S; Liu L; Hao P; Gong Z; Yan Z; Xiang Y
    Mol Med Rep; 2020 Dec; 22(6):5304-5312. PubMed ID: 33174027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. circPARD3 drives malignant progression and chemoresistance of laryngeal squamous cell carcinoma by inhibiting autophagy through the PRKCI-Akt-mTOR pathway.
    Gao W; Guo H; Niu M; Zheng X; Zhang Y; Xue X; Bo Y; Guan X; Li Z; Guo Y; He L; Zhang Y; Li L; Cao J; Wu Y
    Mol Cancer; 2020 Nov; 19(1):166. PubMed ID: 33234130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomal lncRNA LINC02191 Promotes Laryngeal Squamous cell Carcinoma Progression by Targeting miR-204-5p/RAB22A Axis and Regulating PI3K/Akt/mTOR Pathway.
    Kang Z; Zhang C; Huangfu H
    Biochem Genet; 2024 Jun; 62(3):2117-2133. PubMed ID: 37863866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine inhibits the malignant cell phenotype by inactivating PI3K/AKT/mTOR signaling in laryngeal squamous cell carcinoma.
    Lin L; Chen Z; Huang P; Chen W; Zou Z; Zheng Y; He C; Gu X; Yu D; Zhang Q
    Histol Histopathol; 2024 Nov; 39(11):1527-1536. PubMed ID: 38712806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ribophorin II promotes the epithelial-mesenchymal transition and aerobic glycolysis of laryngeal squamous cell carcinoma via regulating reactive oxygen species-mediated Phosphatidylinositol-3-Kinase/Protein Kinase B activation.
    Zhou J; Zhang J; Zhang W; Ke Z; Lv Y; Zhang B; Liao Z
    Bioengineered; 2022 Mar; 13(3):5141-5151. PubMed ID: 35156537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.
    Yang X; Miao S; Mao X; Xiu C; Sun J; Pei R; Jia S
    Pathol Oncol Res; 2021; 27():584466. PubMed ID: 34257531
    [No Abstract]   [Full Text] [Related]  

  • 9. CircCDK1 blocking IGF2BP2-mediated m6A modification of CPPED1 promotes laryngeal squamous cell carcinoma metastasis via the PI3K/AKT signal pathway.
    Li J; Cao H; Yang J; Wang B
    Gene; 2023 Oct; 884():147686. PubMed ID: 37543219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Nucleolar RNA Host Gene 12 (SNHG12) Promotes Proliferation and Invasion of Laryngeal Cancer Cells via Sponging miR-129-5p and Potentiating WW Domain-Containing E3 Ubiquitin Protein Ligase 1 (WWP1) Expression.
    Li J; Sun S; Chen W; Yuan K
    Med Sci Monit; 2019 Jul; 25():5552-5560. PubMed ID: 31348766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CircPRRC2C Promotes the Oncogenic Phenotypes of Laryngeal Squamous Cell Carcinoma Cells via MiR-136-5p/HOXD11 Axis.
    Peng X; Chen X; Peng S; Chen Y; Li Y; Tian Y
    Mol Biotechnol; 2024 Sep; 66(9):2381-2395. PubMed ID: 37728841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis.
    Wu Y; Zhang Y; Zheng X; Dai F; Lu Y; Dai L; Niu M; Guo H; Li W; Xue X; Bo Y; Guo Y; Qin J; Qin Y; Liu H; Zhang Y; Yang T; Li L; Zhang L; Hou R; Wen S; An C; Li H; Xu W; Gao W
    Mol Cancer; 2020 Jun; 19(1):99. PubMed ID: 32487167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative Analysis Reveals STC2 as a Prognostic Biomarker of Laryngeal Squamous Cell Carcinoma.
    Zhong R; Zhan J; Zhang S
    Appl Biochem Biotechnol; 2024 Jul; 196(7):3891-3913. PubMed ID: 37792175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ETS1-LINC00278 negative feedback loop plays a role in COL4A1/COL4A2 regulation in laryngeal squamous cell carcinoma.
    Yang C; Cao H; Yang JW; Wang JT; Yu MM; Wang BS
    Neoplasma; 2022 Jul; 69(4):841-858. PubMed ID: 35532293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin suppresses the malignant phenotype of laryngeal squamous cell carcinoma through downregulating E2F1 to inhibit FLNA.
    Xie Y; Qi J; Liu J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep; 397(9):6929-6939. PubMed ID: 38592439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Farrerol suppresses the progression of laryngeal squamous cell carcinoma via the mitochondria-mediated pathway.
    Zhang T; Liu H; Liu M; Wang C
    Eur J Pharmacol; 2021 Dec; 913():174636. PubMed ID: 34801529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aurora kinase A revives dormant laryngeal squamous cell carcinoma cells via FAK/PI3K/Akt pathway activation.
    Yang LY; He CY; Chen XH; Su LP; Liu BY; Zhang H
    Oncotarget; 2016 Jul; 7(30):48346-48359. PubMed ID: 27356739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tra2β silencing suppresses cell proliferation in laryngeal squamous cell carcinoma via inhibiting PI3K/AKT signaling.
    Ni HS; Hu SQ; Chen X; Liu YF; Ni TT; Cheng L
    Laryngoscope; 2019 Sep; 129(9):E318-E328. PubMed ID: 30597574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hsa_circ_0006232 promotes laryngeal squamous cell cancer progression through FUS-mediated EZH2 stabilization.
    Wu T; Wang G; Zeng X; Sun Z; Li S; Wang W; Yu B
    Cell Cycle; 2021 Sep; 20(18):1799-1811. PubMed ID: 34437823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAGLROS promotes cell proliferation and angiogenesis and inhibits apoptosis by activating multiple signaling pathways in LSCC cells.
    Ma Y; Zhang H; Li X; Liu Y
    J Oral Pathol Med; 2022 Jul; 51(6):510-519. PubMed ID: 34634160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.